ACS
From 2013.igem.org
Line 8: | Line 8: | ||
<strong>The submission deadline is January 17th, 2014.</strong> | <strong>The submission deadline is January 17th, 2014.</strong> | ||
+ | |||
+ | ====Guidelines==== | ||
+ | * The title of the paper should focus on the discovery or new data and not the uber-objective of the team. E.g., if they developed a bacterium to terriform mars, but their data from the summer is a new constitutive promoter, the title should be "A new constitutive promoter with x,y,z properties." No result is too small. | ||
+ | * Small papers ~500-1000 words are preferred. Please limit your submissions to 2-3 page communications. | ||
+ | |||
+ | * iGEM papers will be reviewed by other iGEM teams. | ||
+ | |||
====Instructions==== | ====Instructions==== | ||
If you wish to submit your research to the ACS Synthetic Biology "iGEM 2013" Special Issue (and we hope you do!), please consider the following when preparing your manuscript: | If you wish to submit your research to the ACS Synthetic Biology "iGEM 2013" Special Issue (and we hope you do!), please consider the following when preparing your manuscript: | ||
- | * | + | * In order to submit a paper, you will need to go through the ACS online submission system. You will need to [https://account.acs.org/ssoamweb/account/doSignUp register] for and ACS account first. |
- | + | ||
- | * The abstract again should also avoid the | + | * The abstract again should also avoid the ultimate objective. |
- | * However, the | + | * However, the ultimate objective and broad goals and ideas of the team can be outlined in the introduction and ending. |
* The results again should focus on what is shown. | * The results again should focus on what is shown. | ||
- | |||
* In the introduction and ending, the paper can have information about the organization, challenges, fun things, whichever associated with the team. | * In the introduction and ending, the paper can have information about the organization, challenges, fun things, whichever associated with the team. | ||
* Professional-quality figures are encouraged (i.e. please don’t copy/paste graphs from Excel) | * Professional-quality figures are encouraged (i.e. please don’t copy/paste graphs from Excel) | ||
- | ====Other | + | ====Other details:==== |
- | + | ||
* All submissions must adhere to ACS Synthetic Biology submission guidelines (http://pubs.acs.org/page/asbcd6/submission/authors.html). | * All submissions must adhere to ACS Synthetic Biology submission guidelines (http://pubs.acs.org/page/asbcd6/submission/authors.html). | ||
* ACS Synthetic Biology does not impose any submission, publication, page or color charges. Additional Author Benefits can be found at: http://pubs.acs.org/page/4authors/benefits/index.html. | * ACS Synthetic Biology does not impose any submission, publication, page or color charges. Additional Author Benefits can be found at: http://pubs.acs.org/page/4authors/benefits/index.html. |
Revision as of 22:00, 15 October 2013
Dear iGEMers,
We have teamed up with ACS Publications to offer a iGEM Special Issue for your 2013 projects! We would like to invite all teams to submit original work to ACS Synthetic Biology’s "iGEM 2013" special issue. ACS Synthetic Biology has the highest editorial standards, offers rapid publication of your research findings and imposes NO author submission, page, color, or cover art charges. All accepted submissions will be will be freely accessible on the web as viewpoint pieces.
Teams will also have the opportunity to have their work featured on the cover of the special issue and be interviewed for ACS Synthetic Biology’s monthly podcast series.
The submission deadline is January 17th, 2014.
Guidelines
- The title of the paper should focus on the discovery or new data and not the uber-objective of the team. E.g., if they developed a bacterium to terriform mars, but their data from the summer is a new constitutive promoter, the title should be "A new constitutive promoter with x,y,z properties." No result is too small.
- Small papers ~500-1000 words are preferred. Please limit your submissions to 2-3 page communications.
- iGEM papers will be reviewed by other iGEM teams.
Instructions
If you wish to submit your research to the ACS Synthetic Biology "iGEM 2013" Special Issue (and we hope you do!), please consider the following when preparing your manuscript:
- In order to submit a paper, you will need to go through the ACS online submission system. You will need to register for and ACS account first.
- The abstract again should also avoid the ultimate objective.
- However, the ultimate objective and broad goals and ideas of the team can be outlined in the introduction and ending.
- The results again should focus on what is shown.
- In the introduction and ending, the paper can have information about the organization, challenges, fun things, whichever associated with the team.
- Professional-quality figures are encouraged (i.e. please don’t copy/paste graphs from Excel)
Other details:
- All submissions must adhere to ACS Synthetic Biology submission guidelines (http://pubs.acs.org/page/asbcd6/submission/authors.html).
- ACS Synthetic Biology does not impose any submission, publication, page or color charges. Additional Author Benefits can be found at: http://pubs.acs.org/page/4authors/benefits/index.html.
- In order to submit a paper for review as part of the collection, you must submit your paper via ACS Paragon Plus, which can be accessed at: https://acs.manuscriptcentral.com/acs.
- IMPORTANT: At the time of submission, please choose "iGEM 2013" from the "Special Issue Selection" drop-down menu. Also, please state that your submission is intended for the iGEM 2013 Special Issue in your cover letter.
- The deadline for submitting to the iGEM 2013 Collection is January 17th, 2014.
- Please note that all submissions to ACS Synthetic Biology are subject to peer-review and no guarantee of publication or inclusion into the final issue can be made prior to review.
- Please contact the Managing Editor of ACS Synthetic Biology, Ranjini Prithviraj (r_prithviraj AT acs DOT org) if you have any further questions or concerns.